Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in CDXS — Codexis, Inc.

CIK 19617 NEW YORK, NY
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$94,605
+$27,113 QoQ
Shares Held
41,861
+1.1% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 14% Shared 0% None 86%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. CDXS ranks #272 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in CDXS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $94,605 41,861
2026-03-31 $67,492 41,407
2025-12-31 $66,791 40,977
2025-09-30 $93,539 38,336
2025-06-30 $102,725 42,101
2025-03-31 $125,467 46,643
2024-12-31 $877,229 183,906
2024-09-30 $96,920 31,468
2024-06-30 $96,631 31,172
2024-03-31 $151,513 43,414
2023-12-31 $326,962 107,201
2023-09-30 $534,666 282,893
2023-06-30 $593,848 212,089
2023-03-31 $574,457 138,758
2022-12-31 $446,339 96,095
2022-09-30 $357,164 58,938
2022-06-30 $622,034 59,468
2022-03-31 $1,074,630 52,116
2021-12-31 $1,352,301 43,246
2021-09-30 $631,136 27,134
2021-06-30 $643,588 28,402
2021-03-31 $2,744,281 119,890
2020-12-31 $3,093,288 141,699
2020-09-30 $363,633 30,974
2020-06-30 $307,594 26,982
2020-03-31 $711,057 63,715